三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
2024年艾加莫德销售快速放量(亿美元)
2024年艾加莫德销售快速放量(亿美元)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:72KB
图片尺寸:1137*843
同报告图片
/
4
fCDlubTku70gfCDlsLzmi4nluJXliKkgfCDoib7liqDojqvlvrcgfCDogr/nmKTnlLXlnLrmsrvnlpcgfCDnlLLoi6/no7rphbjlpaXpqaznjq/ntKDniYcgfCDnkZ7mtL7mm7/lsLwgfCDnkZ7mma7mm7/lsLwgfCDoiJLlt7TlnaYr5bqm5rSb5be05Z2mIHwKfC0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMjBBIHwgMC41IHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwKfCAyMDIxQSB8IDEuMCB8IDAuMiB8IDAuMiB8IDAuMiB8IDAuMiB8IDAuMiB8IDAuMiB8CnwgMjAyMkEgfCAxLjUgfCAwLjMgfCAwLjMgfCAwLjMgfCAwLjMgfCAwLjMgfCAwLjMgfAp8IDIwMjNBIHwgMi4wIHwgMC40IHwgMC40IHwgMC40IHwgMC40IHwgMC40IHwgMC40IHwKfCAyMDI0QSB8IDIuNSB8IDAuNSB8IDAuNSB8IDAuNSB8IDAuNSB8IDAuNSB8IDAuNSB8CnwgMjAyNVExIHwgMC42IHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwgMC4xIHwKCui1hOaWmeadpea6kO+8muWGjem8juWMu+iNr+WumOe9keOAgeWGjem8juWMu+iNr+WFrOS8l+WPt+OAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
所属报告:
再鼎医药-港股公司首次覆盖报告:“License~in+自主研发”双轮驱动即将进入发展新阶段-250610(39页).pdf
打包全文图表
相关数据
艾加莫德全球III期临床ADAPT研究安全性数据
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
收藏
行业数据
2025-09-24
原图定位
查看详情
艾加莫德全球III期临床ADAPT研究疗效数据
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
收藏
行业数据
2025-09-24
原图定位
查看详情
艾加莫德海外销售额(1H22-1H25)
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
收藏
行业数据
2025-09-24
原图定位
查看详情
艾加莫德α国内销售额
fCAyNFExIHwgMjRRMiB8IDI0UTMgfCAyNFE0IHwKfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18CnwgMTIwMCAgfCAyMjAwICB8IDI2MDAgIHwgMzAwMCAgfAoK6LWE5paZ5p2l5rqQ77ya5YaN6byO5YWs5Y+45YWs5ZGK77yM5Lit5rOw6K+B5Yi456CU56m25omA
收藏
行业数据
2025-06-23
原图定位
查看详情
ADAPTNXT旨在评估艾加莫德固定周期与均匀给药的临床获益
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
收藏
行业数据
2025-06-12
原图定位
查看详情
艾加莫德皮下注射是国内首个且唯一获批CIDP适应症领域的药物
fCDnlpfmlYggfCDmgqPogIXnmb7liIbmr5QgKCUpIHwKfC0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwKfCDiiaUxICAgIHwgODAuOSAgICAgICAgICAgfAp8IOKJpTIgICAgfCA0Mi43ICAgICAgICAgICB8Cnwg4omlMyAgICB8IDI4LjIgICAgICAgICAgIHwKfCDiiaU0ICAgIHwgMTEuOCAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YaN6byO5Yy76I2v5YWs5ZGK
收藏
行业数据
2025-06-12
原图定位
查看详情
艾加莫德全球销售额逐季度快速增长
fCDml6XmnJ8gfCDoib7liqDojqvlvrflhajnkIPplIDllK7pop3vvIjnmb7kuIfnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjJRMSB8IDUwIHwKfCAyMDIyUTIgfCAxMDAgfAp8IDIwMjJRMyB8IDE1MCB8CnwgMjAyMlE0IHwgMjAwIHwKfCAyMDIzUTEgfCAyNTAgfAp8IDIwMjNRMiB8IDMwMCB8CnwgMjAyM1EzIHwgMzUwIHwKfCAyMDIzUTQgfCA0MDAgfAp8IDIwMjRRMSB8IDQ1MCB8CnwgMjAyNFEyIHwgNTAwIHwKfCAyMDI0UTMgfCA2MDAgfAp8IDIwMjRRNCB8IDcwMCB8CnwgMjAyNVExIHwgODAwIHwKCui1hOaWmeadpea6kO+8mmFyZ2VueCDlubTmiqXjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-06-12
原图定位
查看详情
2024年尼拉帕利、艾加莫德销售占比较大
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
收藏
行业数据
2025-06-12
原图定位
查看详情
艾加莫德全球销售额逐季度快速增长
fCDml6XmnJ8gfCDoib7liqDojqvlvpflhajnkIPplIDllK7pop3vvIjnmb7kuIfnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIyUTEgfCA1MCB8CnwgMjAyMlEyIHwgMTAwIHwKfCAyMDIyUTMgfCAxNTAgfAp8IDIwMjJRNCB8IDIwMCB8CnwgMjAyM1ExIHwgMjUwIHwKfCAyMDIzUTIgfCAzMDAgfAp8IDIwMjNRMyB8IDM1MCB8CnwgMjAyM1E0IHwgNDAwIHwKfCAyMDI0UTEgfCA0NTAgfAp8IDIwMjRRMiB8IDUwMCB8CnwgMjAyNFEzIHwgNjAwIHwKfCAyMDI0UTQgfCA3NTAgfAoK6LWE5paZ5p2l5rqQ77yaYXJnZW54IOW5tOaKpeOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-04-02
原图定位
查看详情
以艾加莫德为代表的FcRn单抗销售额快速增长(亿美元)
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
收藏
行业数据
2025-04-02
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
公司目前共有 8款产品获批上市,自 2019年起平均每年保证 1-2个产品获批节奏。2024年,针对卵巢上皮癌的尼拉帕利销售约 1.87亿美元,同比增长 11%,占比总销售约 46.9%,保持卵巢癌 PARPi院内销售领军者地位。艾加莫德自 2023年 6月上市以来销售额快速增长,2024年实现销售约 9360万美元,同比增长 835%,占比总销售约 23.5%。我们预期,随着在研管线陆续上市以及核心上市产品适应症逐步拓请务必参阅正文后面的信息披露和法律声明 9 / 39 展,公司收入端将迎来强劲增长。
行业数据
原图定位
当前图表所属:
再鼎医药-港股公司首次覆盖报告:“License~in+自主研发”双轮驱动即将进入发展新阶段-250610(39页).pdf
KarXT目前有多个III期临床正在推进中,有成为CNS领域重磅单品潜力
Bemarituzumab目前已开展针对1LFGFR2b过表达胃癌的2个III期临床
贝玛妥珠单抗已进入III期临床,进度大幅领先同靶点竞争对手
HER-2阴性胃癌患者缺乏有效治疗手段
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》